The call sets out to encourage the community to think “outside the box”, to stimulate new and unconventional approaches and creative solutions to the challenges of neurodegeneration research by undertaking high-risk / high-payoff research.
An aim of the CoEN initiative is to build productive links between research groups within recognised CoEs in neurodegeneration. To this end, it is expected that teams will combine the research strengths across CoEs in at least two partner countries to provide a true value-added collaborative effort that will advance our approach to neurodegeneration research. Projects will address issues which would not readily be funded through the standard grant mechanisms of the agencies participating to CoEN, and it is expected that in addition to collaboration across CoEs, projects may also serve to provide a platform for future collaboration with industry.
Within the remit of this call, neurodegeneration applies to: Alzheimer's disease and other dementias, Huntington's disease, Parkinson's disease (PD) and PD-related disorders, Multiple sclerosis, Motor neurone diseases, Prion disease, Spinocerebellar Ataxia and Spinal Muscular Atrophy.
This new call for Pathfinder projects is being launched by six of the nine CoEN members:
Dr. Sheyla Mejia Gervacio CoEN_ANR(at)anr.fr +33 (0) 1 78 09 80 14
The appelsprojetsrecherche.fr portal centralises all information on calls for proposals and calls for applications from ADEME, ANR, Inserm including ANRS, Anses and INCa. It provides a simplified access to upcoming and ongoing calls, giving a greater visibility to funding opportunities. Following their closing date, the calls remain published for a few months.